Collar Capital Management’s Pfizer PFE Stock Holding History

Collar Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Buy	42,473 +1,427	+3%	+$37.3K	0.6%	54
2026 Q1	$1.15M	Buy	41,046 +811	+2%	+$21.6K	0.75%	50
2025 Q4	$1M	Buy	40,235 +1,470	+4%	+$37.1K	0.67%	52
2025 Q3	$988K	Buy	38,765 +3,825	+11%	+$94.4K	0.69%	50
2025 Q2	$847K	Sell	34,940 -1,510	-4%	-$35.2K	0.71%	47
2025 Q1	$924K	Buy	36,450 +8,135	+29%	+$213K	0.84%	49
2024 Q4	$751K	Buy	+28,315	New	+$768K	0.63%	52

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Collar Capital Management's PFE Position: Q2 2026 in Review

Collar Capital Management increased its Pfizer (PFE) stake by 3.5% in Q2 2026, buying an estimated $37.3K and bringing the position to 42,473 shares worth $1.02M. The position accounts for 0.6% of the portfolio, ranked #54.

Collar Capital Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.15M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Collar Capital Management held 42,473 shares of Pfizer worth $1.02M as of Q2 2026.
Collar Capital Management bought 1,427 Pfizer shares in Q2 2026, an estimated $37.3K.
Pfizer made up 0.6% of Collar Capital Management's portfolio in Q2 2026, its #54 holding.
Collar Capital Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Collar Capital Management's Pfizer position peaked at $1.15M in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Collar Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.